The Center for Cancer and Blood Disorders provides comprehensive diagnosis and treatment for a full range of cancers and complex blood disorders, backed by advanced technologies and a multidisciplinary specialist team—with a 1-year survival rate that exceeds international benchmarks.
The 1-year survival rate for cancer patients aged 60 and above is 97% (data from 2019-2024), compared with the International Cancer Benchmarking Partnership's survival benchmark of 65-70%.
Samitivej Srinakarin Hospital has been accredited by the Thai National Stem Cell Donor Registry (TSCDR), under the National Blood Centre, Thai Red Cross Society, as an Unrelated Stem Cell Transplant Center (Hematology). This certification reflects the hospital’s standards in patient care, operational systems, and capability to provide advanced stem cell transplantation for patients requiring complex treatment.

Facilities
articles